Skip to navigation Skip to main content

KEYTRUDA (pembrolizumab) for Non-small Cell Lung Cancer

Slideshow

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

This slideshow reviews drug information for KEYTRUDA (pembrolizumab), indicated for non-small cell lung cancer.

Table of Contents

Slide 3: Indication, Dosage, and Administration
Slide 11: Use in Specific Populations
Slide 14: Clinical Pharmacology
Slide 18: Warnings and Precautions
Slide 24: Clinical Safety and Efficacy
Slide 41: Drug Storage and Supply
Slide 43: References

  • Loading...

    Continuing Medical Education (CME/CE) Courses

    Show More

Next hm-slideshow in Slides